YOLFTbeta
The Klinique Med Clinic PCL

The Klinique Med Clinic PCL

KLINIQ · BK · Consumer Cyclical / Personal Services

37.00THB+3.50 (+10.45%)

Price History

Full chart

Market Stats

Previous Close33.50
Open34.50
Day Range34.25 – 37.25
52-Week Range18.51 – 31.58
Volume2.52M
Market Cap6.10B
P/E (TTM)14.45
Forward P/E13.19
EPS1.92
Dividend Yield6.34%
Beta0.34
50-Day Avg28.67
200-Day Avg25.98

About

The Klinique Medical Clinic Public Company Limited provides skin medical treatment services under the Klinique brand name in Thailand. Its services include face lift, acne, pimples, and acne scars, skin tightening, filler, fat dissolving injection, laser hair removal, skin treatment, skin injection, mesofront, mesotherapy, and rhinoplasty, as well as nose, eye, and facial surgery. The company also offers skin medical services and distribution of cosmetics and medical cosmetics, and surgery services. The Klinique Medical Clinic Public Company Limited was founded in 2009 and is based in Bangkok, Thailand.

Company Details

  • SectorConsumer Cyclical
  • IndustryPersonal Services
  • CEODr. Apiruj Thongwattana
  • Employees0
  • HeadquartersNo. 9 G Tower Grand Rama 9, Bangkok, Thailand, 10310, Thailand
  • Websitehttps://www.theklinique.com

Leadership

  • Dr. Apiruj ThongwattanaCEO & Executive Director · b. 1984
  • Mr. Ratthaphon KittichaitrakulMD, COO, Chief Support Officer & Executive Director · b. 1985
  • Mr. Weerasak SinsapphaiboonMD & Executive Director · b. 1982
  • Mr. Athikom WongsongchaChief Accounting & Financial Officer · b. 1981
  • Mr. Natthapat ChalisarapongChief Marketing Officer · b. 1983
  • Ms. Apiphan CharoenanusornExecutive Director
  • Dr. Mongkon LaoworapongHead of Internal Audit · b. 1970

Financials

Income Statement

Currency: THB2013-12-312014-12-312015-12-312016-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue217.23M442.69M650.24M650.97M808.41M975.84M1.00B949.93M1.64B2.28B2.98B3.56B
Growth (%)-+103.79%+46.88%+0.11%+24.19%+20.71%+2.53%-5.06%+72.54%+39.41%+30.56%+19.22%
Cost of Revenue181.97M366.07M466.42M509.65M384.81M437.14M406.55M391.16M716.07M1.05B1.44B1.76B
Gross Profit35.26M76.62M183.81M141.32M423.60M538.69M594.00M558.77M922.97M1.24B1.54B1.80B
Gross Margin16.23%17.31%28.27%21.71%52.40%55.20%59.37%58.82%56.31%54.05%51.71%50.51%
Operating Expense74.01M121.10M102.32M103.61M411.59M406.88M425.06M405.53M667.22M889.88M1.14B1.33B
Operating Income-38.75M-44.48M81.49M37.71M12.01M131.82M168.94M153.24M255.75M345.16M398.58M463.77M
Operating Margin-17.84%-10.05%12.53%5.79%1.49%13.51%16.88%16.13%15.60%15.11%13.36%13.04%
EBITDA-22.51M-18.90M116.94M79.69M75.44M220.75M246.26M234.43M397.75M559.93M689.20M791.36M
EBITDA Margin-10.36%-4.27%17.98%12.24%9.33%22.62%24.61%24.68%24.27%24.50%23.10%22.25%
Net Income-12.16M-31.92M64.06M32.66M16.76M115.46M144.69M129.26M205.49M288.62M322.19M363.70M
Net Income Margin-5.60%-7.21%9.85%5.02%2.07%11.83%14.46%13.61%12.54%12.63%10.80%10.23%
Interest Expense----220.73K346.53K5.93M4.32M10.66M15.10M23.90M26.34M
Interest Expense % of Total Revenue----0.03%0.04%0.59%0.45%0.65%0.66%0.80%0.74%

Balance Sheet

Currency: THB2013-12-312014-12-312015-12-312016-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets114.34M197.15M263.68M289.06M474.28M681.79M772.09M824.69M2.59B2.85B3.12B3.48B
Total Liabilities92.79M246.51M229.02M242.33M479.86M415.93M660.85M664.18M944.50M1.14B1.40B1.70B
Total Equity21.55M-49.36M34.67M46.73M-5.58M265.86M111.25M160.50M1.65B1.70B1.72B1.77B
Cash4.00M12.02M58.80M35.32M83.38M101.83M9.28M75.91M464.44M108.48M247.91M314.71M
Total Debt10.49M8.25M3.07M3.69M4.67M7.08M212.34M206.99M305.10M461.46M803.56M1.22B
Net Debt6.49M-3.77M-55.73M-31.63M-78.71M-94.76M203.06M131.08M-159.34M352.98M555.65M908.52M

Cash Flow

Currency: THB2013-12-312014-12-312015-12-312016-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow46.81M107.42M101.37M66.25M153.52M208.93M248.26M238.56M407.96M385.92M551.98M671.49M
Investing Cash Flow-41.00M-94.59M-68.17M-67.26M-109.99M-188.62M-24.76M-51.37M-1.23B-421.37M15.79M-168.33M
Financing Cash Flow-2.88M-4.82M13.58M-22.47M-1.30M-1.85M-316.05M-120.57M1.21B-320.51M-428.39M-436.36M
Capital Expenditure41.23M64.79M69.69M68.74M73.43M138.85M148.55M74.03M226.96M367.11M572.81M300.15M
Free Cash Flow5.58M42.63M31.68M-2.48M80.09M70.08M99.71M164.53M181.00M18.81M-20.83M371.35M
Dividends Paid---29.65M--299.20M80.00M153.20M231.00M308.00M319.00M
FCF to OCF11.92%39.69%31.25%-3.75%52.17%33.54%40.16%68.97%44.37%4.87%-3.77%55.30%
Dividend Paid to FCF----1194.18%--300.08%48.62%84.64%1228.31%-1478.47%85.90%

Earnings

Report DateDec 31, 2022May 15, 2023Aug 15, 2023Nov 14, 2023Feb 28, 2024May 14, 2024Aug 14, 2024Nov 13, 2024Feb 27, 2025May 13, 2025Aug 13, 2025Nov 13, 2025Feb 28, 2026May 13, 2026Aug 12, 2026
EPS Estimate0.220.290.320.34-0.350.340.350.390.45-0.370.49-0.51
EPS Actual0.310.310.320.320.350.340.340.340.440.390.410.360.500.550.51
Surprise40.91%6.90%0.00%-5.88%--2.86%0.00%-2.86%12.82%-13.33%--2.70%2.04%-0.00%
Timing-Pre-marketPre-marketPre-market-Pre-marketPre-marketAfter-hoursPre-marketAfter-hours-Pre-marketAfter-hours-After-hours

Key Statistics & Ratios

Market Cap6.10B
Enterprise Value6.05B
Trailing P/E14.45
Forward P/E13.19
PEG Ratio0.82
Price / Sales1.49
Price / Book3.38
EPS1.92
Book Value8.37
Revenue (TTM)4.10B
Gross Profit (TTM)2.09B
EBITDA689.85M
Profit Margin10.29%
Operating Margin13.18%
Return on Equity23.52%
Return on Assets10.51%
Shares Outstanding220.00M
Shares Float75.05M
Beta0.34
Dividend Yield6.34%
Dividend Rate1.76
Payout Ratio84.87%

Dividends

20262×
0.88Aug 27, 20260.75Apr 29, 2026
20252×
0.70Aug 26, 20250.75Apr 29, 2025
20242×
0.65Aug 29, 20240.75Apr 10, 2024
20232×
0.55Aug 29, 20230.50May 8, 2023